USDA Delays DEA-Registered Lab Requirement to December 31, 2026 — What It Means for Hemp Testing

Amid the noise surrounding the November 12, 2026 hemp compliance deadline, a separate and easily overlooked regulatory development has significant implications for hemp testing: the USDA Agricultural Marketing Service has announced it will delay enforcement of the requirement that all hemp be tested by DEA-registered laboratories until December 31, 2026.

This is not an extension of the November 12 product compliance deadline. Those rules remain in place. What has been delayed is a specific, additional requirement — that the labs conducting hemp testing hold DEA registration — which would have taken effect alongside the broader compliance framework. The distinction matters significantly for brands, suppliers, and testing labs navigating the compliance transition.

What the DEA-Registered Lab Requirement Is

Under the new federal hemp framework, hemp testing is not only required to use ISO 17025-accredited third-party laboratories (as has been the standard for compliance documentation). The framework also added a requirement that laboratories testing hemp hold DEA registration.

DEA registration for a testing laboratory is a separate and more involved credential than ISO 17025 accreditation. It requires that the lab register with the Drug Enforcement Administration as a handler of controlled substances — a status that reflects the ambiguity inherent in hemp testing, where labs work with plant material that may contain THC at levels that implicate Schedule I substance handling rules.

Many ISO 17025-accredited hemp testing labs that are currently providing compliant COAs to the industry do not yet hold DEA registration. The testing ecosystem has not fully transitioned to the DEA-registered model, and imposing the requirement immediately would have significantly disrupted lab capacity for the industry right when testing demand is at its highest.

Why the USDA Delayed the Requirement

The USDA’s decision to delay the DEA lab requirement to December 31, 2026 reflects a practical acknowledgment: the current hemp testing laboratory ecosystem isn’t ready. Requiring DEA registration immediately would have:

• Reduced the number of labs available to test hemp, creating bottlenecks at a time when the industry is conducting compliance audits and reformulation testing at scale
• Disrupted ongoing COA workflows for brands that have established relationships with ISO 17025-accredited labs that don’t hold DEA registration
• Potentially invalidated COAs generated during the compliance transition period, creating documentation gaps in exactly the period when documentation most matters

The delay is operationally pragmatic. It gives the testing ecosystem additional time to transition while allowing the product compliance framework (the November 12 deadline, the 0.4mg total THC limit, the total THC calculation) to take effect on its original schedule.

What This Means for Your Testing Strategy Right Now

The DEA lab requirement delay creates a useful window — but it also creates a planning question every hemp brand and supplier needs to address.

Your current ISO 17025-accredited COAs remain valid through December 31, 2026. For compliance documentation purposes, COAs from ISO 17025-accredited labs that don’t hold DEA registration are still compliant testing for the purposes of the November 12 product deadline. The DEA lab requirement is a separate compliance layer that kicks in on December 31.

Starting January 1, 2027, your testing lab needs DEA registration. This is a hard date. After December 31, 2026, a COA from a lab without DEA registration will not satisfy the federal testing standard. Brands and suppliers should be asking their current testing labs now: do you hold DEA registration, or are you in the process of obtaining it? If neither, you need a plan to transition your testing to a DEA-registered lab before year-end.

This is a due diligence question for supplier qualification. If you’re qualifying a new hemp ingredient supplier as part of your compliance transition, add DEA-registered lab status to your vetting criteria. A supplier whose testing lab holds ISO 17025 accreditation AND DEA registration provides documentation that satisfies both layers of the federal testing framework — the November 12 standard and the December 31 standard.

COA transition planning. Some brands may need to transition testing relationships between November 12 and December 31. This is an operational reality to plan for, not a crisis — but it requires awareness and proactive scheduling. Lab transitions take time, and December is not the month you want to be scrambling to establish a new testing relationship.

The Two Deadlines, Clearly Stated

To be absolutely clear on the distinction:

November 12, 2026: Hemp products must comply with the total THC standard (0.4mg per container limit, total THC = delta-9 + THCA × 0.877). Synthetic cannabinoids are prohibited. Testing must be from ISO 17025-accredited third-party labs.

December 31, 2026: In addition to ISO 17025 accreditation, testing labs must hold DEA registration. COAs from non-DEA-registered labs will no longer satisfy the federal testing standard after this date.

Operating compliantly through 2027 requires meeting both deadlines. The November 12 standard is the product compliance standard. The December 31 standard is the testing documentation standard.

LGH Perspective

At Low Gravity Hemp, we’re monitoring the DEA lab registration transition actively. We are committed to ensuring that our testing documentation satisfies both the November 12 product compliance standard and the December 31 DEA lab registration requirement. As the testing ecosystem transitions, we’ll be proactive about communicating any changes in our testing lab relationships to our customers — because seamless COA continuity is part of the service we provide. If you have questions about how this affects the COA documentation we provide for your specific ingredients, reach out.

Final Thoughts

The USDA’s delay of the DEA lab requirement gives the hemp testing ecosystem needed breathing room — but it doesn’t eliminate the requirement, it defers it. Brands that understand the two-deadline structure and plan for both will have continuous, compliant testing documentation through the transition. Brands that only focus on November 12 and miss the December 31 DEA lab requirement will face a documentation gap right when regulators, retailers, and partners are scrutinizing COAs most carefully.

Questions about your testing documentation and lab registration status? Contact Low Gravity Hemp to discuss our testing protocols and how DEA lab registration affects our compliance documentation for your ingredient supply.